Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test

Journal of Clinical Virology

Volumn 61, Issue 4, 2014, Pages 548-552

  Bernal, Samuel ^a   Palomares, Jose C ^a   Artura, Antonio ^a   Parra, Manuel ^a   Cabezas, Jose L ^a   Robles, Antonio ^a   Martín Mazuelos, Estrella ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Cobas 4800; Genotyping; Papillomavirus; Urine

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; FEMALE; GENOTYPE; HISTOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; URINALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; EVALUATION STUDY; GENETICS; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; URINE; UTERINE CERVIX; VIROLOGY;

CERVIX UTERI; DNA, VIRAL; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; URINE;

EID: 84922733382     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2014.10.001     Document Type: Article

References (23)

1. Zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1996, 1288(2):F55-F78.
2. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.Y., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
3. de Sanjose S., Quint W.G., Alemany L., Geraets D.T., Klaustermeier J.E., Lloveras, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010, 1048-1056.
4. Safaeian M., Solomon D., Castle P.E. Cervical cancer prevention - cervical screening: science in evolution. Obstet Gynecol Clin North Am 2007, 34:739-760.
5. Bulkmans N.W.J., Berkhof J., Rozendaal L., van Kemenade F.J., Boeke A.J.P., Bulk S., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007, 24:1764-1772.
6. Kitchener H.C., Almonte M., Thomson C., Wheeler P., Sargent A., Stoykova B., et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009, 10:672-682.
7. Ronco G., Giorgi-Rossi P., Carozzi F., Confortini M., Dalla Palma P., Del Mistro A., et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010, 11:249-257.
8. Rijkaart D.C., Berkhof J., Rozendaal L., van Kemenade F.J., Bulkmans N.W.J., Heideman D.A.M., et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial 2012, January, vol 13. http://www.thelancet.com/oncology.
9. Ronco G., Dillner J., Elfstrom K.M., Tunesi S., Snijders P.J., Arbyn M., et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014, 383(February (9916)):524-532. 10.1016/S0140-6736(13)62218-7.
10. Parra M., Palomares J.C., Bernal S., González M.T., Sivianes N., Pérez L., et al. Evaluation of the cobas 4800 CT/NG Test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital swabs and urine specimens. Diag Microbiol Infect Dis 2012, 74:338-342.
11. Papp J.R., Schachter J., Gaydos C.A., Van Der Pol B. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae. MMWR 2014, (March).
12. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
13. Roche Molecular Systems Cobas 4800 HPV test, for in vitro diagnostic use: package insert 2010, Roche Molecular Systems, Pleasanton, CA.
14. Tanzi E., Bianchi S., Fasolo M.M., Frati E.R., Mazza F., Martinelli M., et al. High Performance of a new PCR-based urine assay for HPV-DNA detection and genotyping. J Med Virol 2013, 85:91-98.
15. Sahasrabuddhe V., Gravitt P.E., Dunn S.T., Brown D., Allen R.A., Eby Y.J., et al. Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol 2014, 52:187-192.
16. Brinkman J.A., Jones W.E., Gaffga A.M., Sanders J.A., Chaturvedi A.K., Slavinsky J., et al. Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol 2002, 3155-3161.
17. Daponte A., Pournaras S., Mademtzis I., Hadjichristodoulou C., Kostopoulou E., Maniatis A.N., et al. Evaluation of high-risk human papillomavirus types PCR detection in paired urine and cervical samples of women with abnormal cytology. J Clin Virol 2006, 36(3):189-193.
18. Bissett S.L., Howell-Jones R., Swift C., de Silva N., Biscornet L., Parry J.V., et al. Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and males. J Med Virol 2011, 83:1744-1751.
19. Sehgal A., Gupta S., Parashari A., Sodhani P., Singh V. Urine HPV-DNA detection for cervical cancer screening: prospects and prejudices. J Obstet Gynecol 2009, 29:583-589.
20. Vorsters A., Micalessi I., Bileke J., Leven M., Bogers J., Van Damme P. Detection of human papillomavirus DNA in urine. A review of the literature. Eu J Clin Microbiol Infect Dis 2011, 627-640.
21. Payan C., Ducancelle A., Aboubaker M.H., Caer J., Tapia M., Chauvin A., et al. Human papillomavirus quantification in urine and cervical samples by using the Mx4000 and LightCycler general real-time PCR systems. J Clin Microbiol 2007, 45(3):897-901.
22. Mendez K., Romaguera J., Ortiz A.P., López M., Steinau M., Unger E.R. Urine-based human papillomavirus DNA testing as a screening tool for cervical cancer in high-risk women International. J Gynecol Obstet 2014, 124:151-155.
23. Song E.S., Lee H.J., Hwang T.S. Clinical efficacy of human papillomavirus DNA detection in urine from patients with various cervical lesions. J Korean Med Sci 2007, 22:99-104.